Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- befree-2016 importedOn "2016-02-19" NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion wasGeneratedBy ECO_0000203 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion wasDerivedFrom befree-2016 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion SIO_000772 21196304 NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion evidence source_evidence_literature NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.
- NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_assertion description "[In the present study, we found that the CD44(+)/CD24(-/low) CSCs, isolated from both human breast cell line MCF-7 and MDA-MB-231, were more resistant to thiotepa, paclitaxel and anthracycline, when compared with the non-breast cancer stem cell subset from the same cell lines, whereas the chemosensitivities were remarkably reversed by higher concentration of thiotepa and paclitaxel except for adriamycin.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP862472.RAuQCw3mHrWaDYCX31TnOPF1ldFz8cBfLmKw06_miS80Q130_provenance.